Starget Pharma

Ramat HaSharon, Israel · Founded 2019 · Privately Held (backing)

Operator of a biotechnology company intended to specialize in the diagnosis and targeted treatment of cancer using targeted radioactive radiation. Starget Pharma is based in Ramat HaSharon, Israel and was founded in 2019. It has raised $37.3 million across 1 recorded round; the latest was a $16.4 million early-stage round in Jan 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$37.3M
Last round
Early Stage VC
Jan 2026

Who backs Starget Pharma?

8 investors
InvestorType
Louisiana Economic DevelopmentOther
2b AHEAD Ventures—
ARC Innovation Center—
BRF(Shreveport)—
BVM Capital—
Cancer Focus Fund—
Ilex Medical—
Ramot at Tel Aviv University—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Starget Pharma investors

8 investors are on record for Starget Pharma, including Louisiana Economic Development, 2b AHEAD Ventures, ARC Innovation Center and BRF(Shreveport). The early-stage round in Jan 2026 drew 29 investors.

Free account
More of Starget Pharma with a free account
  • ·Watch Starget Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Starget Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View